Phase II-III Study of an Optimized LV-5FU-Oxaliplatin Strategy in Metastatic Colorectal Cancer. Optimox2 Study. C02-2.

Trial Profile

Phase II-III Study of an Optimized LV-5FU-Oxaliplatin Strategy in Metastatic Colorectal Cancer. Optimox2 Study. C02-2.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms Optimox-2
  • Most Recent Events

    • 28 Sep 2009 Primary endpoint 'Duration of disease control' has not been met according to Journal of Clinical Oncology article.
    • 28 Sep 2009 Results published online in Journal of Clinical Oncology.
    • 20 Jun 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top